FDA clears Pfiz­er's Covid-19 vac­cine for chil­dren ages 5-11

The FDA has giv­en Pfiz­er-BioN­Tech’s Covid-19 vac­cine the go-ahead for emer­gency use in chil­dren be­tween the ages of 5 and 11, mak­ing it pos­si­ble for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.